InvestorsHub Logo
Followers 7
Posts 650
Boards Moderated 1
Alias Born 06/02/2009

Re: None

Wednesday, 10/20/2010 9:56:51 AM

Wednesday, October 20, 2010 9:56:51 AM

Post# of 240
The company’s current commercial efforts are focused on GLUMETZA® (metformin hydrochloride extended release tablets) and CYCLOSET® (bromocriptine mesylate) tablets, which are indicated as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes. The company expects to commercially launch CYCLOSET in November 2010.

ASCO Annual Meeting, June 4-9, 2010, Chicago IL